# OnCo record paper-ve-basket-vemurafenib-erdheim-chester-lch-jama-oncol-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ve-basket-vemurafenib-erdheim-chester-lch-jama-oncol-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ve-basket-vemurafenib-erdheim-chester-lch-jama-oncol-2018" ;
  schema:name "VE-BASKET: vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis"@en ;
  schema:description "The BRAF inhibitor vemurafenib shrank disease in most adults with BRAF-mutant Erdheim-Chester disease, and the responses lasted, leading to the first drug approval for this histiocytosis."@en ;
  schema:url <https://onco.cc/key-papers/paper-ve-basket-vemurafenib-erdheim-chester-lch-jama-oncol-2018/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2017.5029>, <https://pubmed.ncbi.nlm.nih.gov/29188284/> ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2017.5029> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Diamond EL, Subbiah V, Lockhart AC, et al." ;
  onco:cancers <https://onco.cc/cancers/erdheim-chester-disease/> ;
  onco:drugs <https://onco.cc/drugs/vemurafenib/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .